Joint effects of GP6 rs1613662 and pre-cancer platelet count on the risk of venous thromboembolism in cancer

Hanne Skille; Olga V. Gran; Benedikte Paulsen; Emily Smith; Sigrid K. Brækkan; Terry Solomon; Frits R. Rosendaal; Kelly A. Frazer; John‐Bjarne Hansen

doi:10.1016/j.thromres.2018.02.042

Related publications

Letter2019

Genetic variation of platelet glycoprotein VI and the risk of venous thromboembolism

Hanne Skille, Benedikte Paulsen, Kristian Hveem, Maiken E. Gabrielsen, Ben Brumpton, Kristian Hindberg, Olga V. Gran, Frits R. Rosendaal, Sigrid K. Brækkan, John‐Bjarne Hansen

Haematologica

Article2018

The impact of FGG rs2066865 and pre-cancer fibrinogen concentration on cancer-related venous thromboembolism (VTE)

Benedikte Paulsen, Olga V. Gran, Hanne Skille, Erin N. Smith, Sigrid K. Brækkan, Terry Solomon, Frits R. Rosendaal, Kelly A. Frazer, John‐Bjarne Hansen

Thrombosis Research

Letter2011

Venous Thromboembolism

Henri Bounameaux, Frits R. Rosendaal

Circulation

Letter1999

Venous thromboembolism and oral contraceptives

Kitty W.M. Bloemenkamp, Frits R. Rosendaal, Frans M. Helmerhorst, Jan P. Vandenbroucke

The Lancet

Letter2000

Antipsychotic drugs and venous thromboembolism

René Thomassen, Jan P. Vandenbroucke, Frits R. Rosendaal